220 related articles for article (PubMed ID: 36232484)
1. Analysis of the Effects of Ninjin'yoeito on Physical Frailty in Mice.
Otsuka S; Fukumaru K; Tani A; Takada S; Kikuchi K; Norimatsu K; Matsuzaki R; Matsuoka T; Sakakima H; Omiya Y; Mizuno K; Matsubara Y; Maruyama I
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232484
[TBL] [Abstract][Full Text] [Related]
2. Ninjin'yoeito reduces fatigue-like conditions by alleviating inflammation of the brain and skeletal muscles in aging mice.
Otsuka S; Matsuzaki R; Kakimoto S; Tachibe Y; Kawatani T; Takada S; Tani A; Nakanishi K; Matsuoka T; Kato Y; Inadome M; Nojima N; Sakakima H; Mizuno K; Matsubara Y; Maruyama I
PLoS One; 2024; 19(5):e0303833. PubMed ID: 38768175
[TBL] [Abstract][Full Text] [Related]
3. Disuse muscle atrophy-improving effect of ninjin'yoeito in a mouse model.
Takemoto R; Sejima T; Han LK; Michihara S; Takahashi R
Neuropeptides; 2021 Dec; 90():102199. PubMed ID: 34610544
[TBL] [Abstract][Full Text] [Related]
4. Effects of Ninjin'yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial.
Ohbayashi H; Ariga M; Ohta K; Kudo S; Furuta O; Yamamoto A
Int J Chron Obstruct Pulmon Dis; 2024; 19():995-1010. PubMed ID: 38737191
[TBL] [Abstract][Full Text] [Related]
5. Herbal Medicine Ninjin'yoeito in the Treatment of Sarcopenia and Frailty.
Uto NS; Amitani H; Atobe Y; Sameshima Y; Sakaki M; Rokot N; Ataka K; Amitani M; Inui A
Front Nutr; 2018; 5():126. PubMed ID: 30619872
[TBL] [Abstract][Full Text] [Related]
6. Improvement in Frailty in a Patient With Severe Chronic Obstructive Pulmonary Disease After Ninjin'yoeito Therapy: A Case Report.
Kuniaki H; Akihiko T; Tetsuya H; Hatsuko M; Tomoko K; Shin O; Sojiro K; Mayumi Y; Fumihiro Y; Shintaro S; Tsukasa O; Hironori S
Front Nutr; 2018; 5():71. PubMed ID: 30234120
[TBL] [Abstract][Full Text] [Related]
7. Long-term administration of ninjin'yoeito to treat frailty in older adults: A case series.
Sakisaka N
Neuropeptides; 2022 Jun; 93():102244. PubMed ID: 35381491
[TBL] [Abstract][Full Text] [Related]
8. Ninjin'yoeito, a traditional Japanese medicine, increases dopamine content in PC12 cells.
Miyazaki S; Omiya Y; Mizoguchi K
Biosci Biotechnol Biochem; 2021 Oct; 85(11):2274-2280. PubMed ID: 34529031
[TBL] [Abstract][Full Text] [Related]
9. Good Rehabilitation Outcomes and Improved Nutritional Status After Treatment With the Japanese Herbal Medicine Ninjin'yoeito in an Elderly Patient With Hip Fracture and Sarcopenia: A Case Report.
Morinaga A; Nakamura H; Hattanmaru K; Rokot NT; Kimura Y; Ito T
Front Nutr; 2020; 7():85. PubMed ID: 32714940
[TBL] [Abstract][Full Text] [Related]
10. Ninjin'yoeito Targets Distinct Ca
Goswami C; Dezaki K; Wang L; Inui A; Seino Y; Yada T
Front Nutr; 2020; 7():104. PubMed ID: 32766273
[TBL] [Abstract][Full Text] [Related]
11. Safety and Effectiveness of Ninjin'yoeito: A Utilization Study in Elderly Patients.
Suzuki S; Aihara F; Shibahara M; Sakai K
Front Nutr; 2019; 6():14. PubMed ID: 30873411
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic study of Ninjin'yoeito: Absorption and brain distribution of Ninjin'yoeito ingredients in mice.
Matsumoto T; Takiyama M; Sakamoto T; Kaifuchi N; Watanabe J; Takahashi Y; Setou M
J Ethnopharmacol; 2021 Oct; 279():114332. PubMed ID: 34129897
[TBL] [Abstract][Full Text] [Related]
13. Impact of Ninjin'yoeito on frailty and short life in klotho-hypomorphic (kl/kl) mice.
Amitani H; Chiba S; Amitani M; Michihara S; Takemoto R; Han L; Fujita N; Takahashi R; Inui A
Front Pharmacol; 2022; 13():973897. PubMed ID: 36353482
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Ninjin'yoeito May Improve Quality of Life After Hospitalization for Acute Illness in Patients With Frailty.
Kashima M
Front Nutr; 2021; 8():547512. PubMed ID: 33937301
[No Abstract] [Full Text] [Related]
15. Onion component, isoalliin, stimulates feeding and activates the arcuate nucleus neuropeptide Y, ghrelin- and Ninjin'yoeito-responsive neurons.
Wang L; Han W; Iwasaki Y; Yermek R; Sharp GWG; Seino Y; Yada T
Neuropeptides; 2021 Oct; 89():102180. PubMed ID: 34293597
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the usefulness of Ninjin'yoeito Kampo medicine in combination with rehabilitation therapy in patients with frailty complicated by intractable dizziness.
Arai M
Neuropeptides; 2021 Dec; 90():102189. PubMed ID: 34481223
[TBL] [Abstract][Full Text] [Related]
17. A Clinical Study of Ninjin'yoeito With Regard to Frailty.
Sakisaka N; Mitani K; Sempuku S; Imai T; Takemoto Y; Shimomura H; Ushiroyama T
Front Nutr; 2018; 5():73. PubMed ID: 30320119
[TBL] [Abstract][Full Text] [Related]
18. Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study.
Ito T; Konishi A; Tsubokura Y; Azuma Y; Hotta M; Yoshimura H; Nakanishi T; Fujita S; Nakaya A; Satake A; Ishii K; Nomura S
Front Nutr; 2018; 5():72. PubMed ID: 30186837
[TBL] [Abstract][Full Text] [Related]
19. Ninjin'yoeito, a traditional Japanese medicine, attenuates age-related deficits of muscle performance, self-care motivation, and body temperature in C57BL/6 mice.
Matsubara Y; Miyama Y; Imai R; Oizumi H; Miyazaki S; Haneda E; Mizuno K; Omiya Y; Ikeda Y; Mizoguchi K
Biosci Biotechnol Biochem; 2022 Jun; 86(7):895-901. PubMed ID: 35396846
[TBL] [Abstract][Full Text] [Related]
20. Ninjin'yoeito Improves Genitourinary Symptoms in Patients With Frailty.
Okui N; Okui MA
Cureus; 2023 Jun; 15(6):e40767. PubMed ID: 37363115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
